Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajita Menon

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Physical Review Letters|May 9, 2015
Public good diffusion limits microbial mutualismRajita Menon, Kirill S Korolev
Plos Computational Biology|January 17, 2018
Interactions between species introduce spurious associations in microbiome studiesRajita Menon, Vivek Ramanan, Kirill S Korolev
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 1, 2021
Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi childrenMohammad I El Mouzan, Harland S Winter, Ahmed A Al Sarkhy, et al.
Nature Medicine|January 3, 2025
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infectionRajita Menon, Shakti K Bhattarai, Emily Crossette, et al.
Gut Pathogens|December 7, 2018
Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western populationMohammad I El Mouzan, Harland S Winter, Assad A Assiri, et al.
World Journal of Gastroenterology|October 26, 2018
Fungal dysbiosis predicts the diagnosis of pediatric Crohn's diseaseMohammad I El Mouzan, Kirill S Korolev, Mohammad A Al Mofarreh, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adultsJeffrey L Silber, Jason M Norman, Tokuwa Kanno, et al.
Gut Microbes|August 4, 2025
Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trialBas Groenewegen, Merel M Ruissen, Emily Crossette, et al.
Journal of Crohn'S & Colitis|November 5, 2016
Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's DiseaseMohammad El Mouzan, Feng Wang, Mohammad Al Mofarreh, et al.
JAMA|April 15, 2023
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialThomas Louie, Yoav Golan, Sahil Khanna, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Physical Review Letters|May 9, 2015
Public good diffusion limits microbial mutualismRajita Menon, Kirill S Korolev
Plos Computational Biology|January 17, 2018
Interactions between species introduce spurious associations in microbiome studiesRajita Menon, Vivek Ramanan, Kirill S Korolev
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 1, 2021
Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi childrenMohammad I El Mouzan, Harland S Winter, Ahmed A Al Sarkhy, et al.
Nature Medicine|January 3, 2025
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infectionRajita Menon, Shakti K Bhattarai, Emily Crossette, et al.
Gut Pathogens|December 7, 2018
Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western populationMohammad I El Mouzan, Harland S Winter, Assad A Assiri, et al.
World Journal of Gastroenterology|October 26, 2018
Fungal dysbiosis predicts the diagnosis of pediatric Crohn's diseaseMohammad I El Mouzan, Kirill S Korolev, Mohammad A Al Mofarreh, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adultsJeffrey L Silber, Jason M Norman, Tokuwa Kanno, et al.
Gut Microbes|August 4, 2025
Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trialBas Groenewegen, Merel M Ruissen, Emily Crossette, et al.
Journal of Crohn'S & Colitis|November 5, 2016
Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's DiseaseMohammad El Mouzan, Feng Wang, Mohammad Al Mofarreh, et al.
JAMA|April 15, 2023
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialThomas Louie, Yoav Golan, Sahil Khanna, et al.
Pageof 2